4049

Basic information

Claribaccin is a pharmaceutical product that contains clarithromycin as its active ingredient. Clarithromycin is a semisynthetic macrolide antibiotic that is derived by substituting the CN3O hydroxyl group with an (OH) group in the 6th position of the lactone ring of erythromycin. This modification results in the formation of 6-Omethylerythromycin A, which is the main component of clarithromycin.

The mechanism of action of clarithromycin involves its ability to bind to the 50S ribosomal subunit of susceptible bacteria. By doing so, it effectively prevents the translocation of activated amino acids, thereby inhibiting intracellular protein synthesis in these microorganisms. This inhibition of protein synthesis is crucial for clarithromycin to exert its antibacterial action against susceptible bacteria.

Clarithromycin's antibacterial properties make it a valuable tool in the treatment of various infections caused by bacteria that are sensitive to its effects. It belongs to the macrolide class of antibiotics, which are commonly used in the medical industry for their effectiveness against a wide range of bacterial pathogens. Claribaccin, with its active ingredient clarithromycin, provides a reliable and essential solution for combating bacterial infections in numerous healthcare settings.